vs
ALAMO GROUP INC(ALG)与REPLIGEN CORP(RGEN)财务数据对比。点击上方公司名可切换其他公司
ALAMO GROUP INC的季度营收约是REPLIGEN CORP的1.9倍($373.6M vs $197.9M),REPLIGEN CORP净利率更高(6.7% vs 4.2%,领先2.6%),REPLIGEN CORP同比增速更快(13.6% vs -3.0%),ALAMO GROUP INC自由现金流更多($69.9M vs $17.6M),过去两年REPLIGEN CORP的营收复合增速更高(14.4% vs -6.3%)
Alamo Drafthouse Cinema是1997年在美国得克萨斯州奥斯汀成立的连锁影院品牌,主打观影期间提供餐食与饮品服务,同时严格要求观众遵守观影礼仪,2024年6月该连锁品牌被索尼影视体验部门收购。
Repligen是一家全球生命科学企业,专注于创新生物工艺技术与系统的研发及商业化,助力提升生物药生产效率。公司1981年成立,总部位于美国马萨诸塞州沃尔瑟姆,于纳斯达克挂牌上市,股票代码RGEN,截至2025年全球员工超1900人,主要服务生物制药领域客户。
ALG vs RGEN — 直观对比
营收规模更大
ALG
是对方的1.9倍
$197.9M
营收增速更快
RGEN
高出16.7%
-3.0%
净利率更高
RGEN
高出2.6%
4.2%
自由现金流更多
ALG
多$52.3M
$17.6M
两年增速更快
RGEN
近两年复合增速
-6.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $373.6M | $197.9M |
| 净利润 | $15.5M | $13.3M |
| 毛利率 | 22.7% | 52.5% |
| 营业利润率 | 6.0% | 9.0% |
| 净利率 | 4.2% | 6.7% |
| 营收同比 | -3.0% | 13.6% |
| 净利润同比 | -44.8% | 143.9% |
| 每股收益(稀释后) | $1.28 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ALG
RGEN
| Q4 25 | $373.6M | $197.9M | ||
| Q3 25 | $420.0M | $188.8M | ||
| Q2 25 | $419.1M | $182.4M | ||
| Q1 25 | $390.9M | $169.2M | ||
| Q4 24 | $385.3M | $174.1M | ||
| Q3 24 | $401.3M | $154.9M | ||
| Q2 24 | $416.3M | $154.1M | ||
| Q1 24 | $425.6M | $151.3M |
净利润
ALG
RGEN
| Q4 25 | $15.5M | $13.3M | ||
| Q3 25 | $25.4M | $14.9M | ||
| Q2 25 | $31.1M | $14.9M | ||
| Q1 25 | $31.8M | $5.8M | ||
| Q4 24 | $28.1M | $-30.3M | ||
| Q3 24 | $27.4M | $-654.0K | ||
| Q2 24 | $28.3M | $3.3M | ||
| Q1 24 | $32.1M | $2.1M |
毛利率
ALG
RGEN
| Q4 25 | 22.7% | 52.5% | ||
| Q3 25 | 24.2% | 53.2% | ||
| Q2 25 | 25.8% | 50.0% | ||
| Q1 25 | 26.3% | 53.6% | ||
| Q4 24 | 23.8% | 26.1% | ||
| Q3 24 | 25.1% | 50.0% | ||
| Q2 24 | 26.0% | 49.8% | ||
| Q1 24 | 26.2% | 49.5% |
营业利润率
ALG
RGEN
| Q4 25 | 6.0% | 9.0% | ||
| Q3 25 | 8.9% | 8.9% | ||
| Q2 25 | 11.2% | 7.6% | ||
| Q1 25 | 11.4% | 3.9% | ||
| Q4 24 | 8.9% | -17.7% | ||
| Q3 24 | 10.0% | -5.1% | ||
| Q2 24 | 10.4% | 1.0% | ||
| Q1 24 | 11.0% | 1.3% |
净利率
ALG
RGEN
| Q4 25 | 4.2% | 6.7% | ||
| Q3 25 | 6.0% | 7.9% | ||
| Q2 25 | 7.4% | 8.2% | ||
| Q1 25 | 8.1% | 3.4% | ||
| Q4 24 | 7.3% | -17.4% | ||
| Q3 24 | 6.8% | -0.4% | ||
| Q2 24 | 6.8% | 2.2% | ||
| Q1 24 | 7.5% | 1.4% |
每股收益(稀释后)
ALG
RGEN
| Q4 25 | $1.28 | $0.24 | ||
| Q3 25 | $2.10 | $0.26 | ||
| Q2 25 | $2.57 | $0.26 | ||
| Q1 25 | $2.64 | $0.10 | ||
| Q4 24 | $2.33 | $-0.55 | ||
| Q3 24 | $2.28 | $-0.01 | ||
| Q2 24 | $2.35 | $0.06 | ||
| Q1 24 | $2.67 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $309.7M | $767.6M |
| 总债务越低越好 | $190.7M | $542.2M |
| 股东权益账面价值 | $1.1B | $2.1B |
| 总资产 | $1.6B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.17× | 0.26× |
8季度趋势,按日历期对齐
现金及短期投资
ALG
RGEN
| Q4 25 | $309.7M | $767.6M | ||
| Q3 25 | $244.8M | $748.7M | ||
| Q2 25 | $201.8M | $708.9M | ||
| Q1 25 | $200.3M | $697.2M | ||
| Q4 24 | $197.3M | $757.4M | ||
| Q3 24 | $140.0M | $784.0M | ||
| Q2 24 | $118.5M | $809.1M | ||
| Q1 24 | $121.8M | $780.6M |
总债务
ALG
RGEN
| Q4 25 | $190.7M | $542.2M | ||
| Q3 25 | $194.4M | $537.9M | ||
| Q2 25 | $198.1M | — | ||
| Q1 25 | $201.8M | — | ||
| Q4 24 | $205.5M | $525.6M | ||
| Q3 24 | $209.2M | — | ||
| Q2 24 | $278.6M | — | ||
| Q1 24 | $306.5M | — |
股东权益
ALG
RGEN
| Q4 25 | $1.1B | $2.1B | ||
| Q3 25 | $1.1B | $2.1B | ||
| Q2 25 | $1.1B | $2.1B | ||
| Q1 25 | $1.1B | $2.0B | ||
| Q4 24 | $1.0B | $2.0B | ||
| Q3 24 | $1.0B | $2.0B | ||
| Q2 24 | $979.7M | $2.0B | ||
| Q1 24 | $956.6M | $2.0B |
总资产
ALG
RGEN
| Q4 25 | $1.6B | $2.9B | ||
| Q3 25 | $1.6B | $2.9B | ||
| Q2 25 | $1.6B | $2.9B | ||
| Q1 25 | $1.5B | $2.9B | ||
| Q4 24 | $1.5B | $2.8B | ||
| Q3 24 | $1.5B | $2.8B | ||
| Q2 24 | $1.5B | $2.9B | ||
| Q1 24 | $1.5B | $2.8B |
负债/权益比
ALG
RGEN
| Q4 25 | 0.17× | 0.26× | ||
| Q3 25 | 0.17× | 0.26× | ||
| Q2 25 | 0.18× | — | ||
| Q1 25 | 0.19× | — | ||
| Q4 24 | 0.20× | 0.27× | ||
| Q3 24 | 0.21× | — | ||
| Q2 24 | 0.28× | — | ||
| Q1 24 | 0.32× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $75.1M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $69.9M | $17.6M |
| 自由现金流率自由现金流/营收 | 18.7% | 8.9% |
| 资本支出强度资本支出/营收 | 1.4% | 4.1% |
| 现金转化率经营现金流/净利润 | 4.84× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $146.9M | $93.9M |
8季度趋势,按日历期对齐
经营现金流
ALG
RGEN
| Q4 25 | $75.1M | $25.7M | ||
| Q3 25 | $65.5M | $48.1M | ||
| Q2 25 | $22.7M | $28.6M | ||
| Q1 25 | $14.2M | $15.0M | ||
| Q4 24 | $79.1M | $39.2M | ||
| Q3 24 | $96.3M | $49.3M | ||
| Q2 24 | $33.2M | $42.2M | ||
| Q1 24 | $1.1M | $44.7M |
自由现金流
ALG
RGEN
| Q4 25 | $69.9M | $17.6M | ||
| Q3 25 | $53.1M | $43.4M | ||
| Q2 25 | $15.7M | $21.5M | ||
| Q1 25 | $8.2M | $11.4M | ||
| Q4 24 | $73.1M | $33.6M | ||
| Q3 24 | $88.4M | $42.3M | ||
| Q2 24 | $28.8M | $37.4M | ||
| Q1 24 | $-5.5M | $36.4M |
自由现金流率
ALG
RGEN
| Q4 25 | 18.7% | 8.9% | ||
| Q3 25 | 12.6% | 23.0% | ||
| Q2 25 | 3.8% | 11.8% | ||
| Q1 25 | 2.1% | 6.8% | ||
| Q4 24 | 19.0% | 19.3% | ||
| Q3 24 | 22.0% | 27.3% | ||
| Q2 24 | 6.9% | 24.3% | ||
| Q1 24 | -1.3% | 24.0% |
资本支出强度
ALG
RGEN
| Q4 25 | 1.4% | 4.1% | ||
| Q3 25 | 3.0% | 2.5% | ||
| Q2 25 | 1.7% | 3.9% | ||
| Q1 25 | 1.5% | 2.1% | ||
| Q4 24 | 1.6% | 3.2% | ||
| Q3 24 | 2.0% | 4.5% | ||
| Q2 24 | 1.1% | 3.1% | ||
| Q1 24 | 1.6% | 5.5% |
现金转化率
ALG
RGEN
| Q4 25 | 4.84× | 1.93× | ||
| Q3 25 | 2.58× | 3.23× | ||
| Q2 25 | 0.73× | 1.92× | ||
| Q1 25 | 0.45× | 2.57× | ||
| Q4 24 | 2.82× | — | ||
| Q3 24 | 3.51× | — | ||
| Q2 24 | 1.17× | 12.70× | ||
| Q1 24 | 0.03× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALG
| Wholegood Units | $293.2M | 78% |
| Parts | $61.6M | 16% |
| Other Revenue | $18.9M | 5% |
RGEN
暂无分部数据